Phase
Condition
Non-small Cell Lung Cancer
Treatment
Lorlatinib
Clinical Study ID
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
1 - Any participant who is receiving study treatment and deriving clinical benefit (as determined by the Principal Investigator) in a Pfizer-sponsored Lorlatinib Parent Study.
2- Participants must agree to follow the reproductive criteria. 3- Adequate Bone Marrow, Liver, Renal, Pancreatic Function
Exclusion
Exclusion Criteria:
1 - Female participants who are pregnant or breastfeeding. 2- Any medical reason that, in the opinion of the Investigator or Sponsor, precludes the participant from inclusion in the study.
Study Design
Connect with a study center
The First affiliated Hospital of Anhui Medical University
Hefei, Anhui 230022
ChinaSite Not Available
Beijing Cancer Hospital
Beijing, Beijing 100142
ChinaSite Not Available
Fujian Cancer Hospital
Fuzhou, Fujian 350014
ChinaSite Not Available
Guangdong Provincial People's Hospital
Guangzhou, Guangdong 510080
ChinaSite Not Available
Hunan Cancer Hospital
Changsha, Hunan 410006
ChinaSite Not Available
General Hospital of Eastern Theater Command
Nanjing, Jiangsu 210002
ChinaSite Not Available
Jilin Cancer Hospital
Changchun, Jilin 130000
ChinaSite Not Available
The first hospital of jilin university
Changchun City, Jilin 130021
ChinaSite Not Available
Sir Run Shaw Hospital
Hangzhou, Qiantang District 310016
ChinaSite Not Available
The Second Affiliated Hospital of PLA Air Force Medical University
Xi'an City, Shaanxi 710038
ChinaSite Not Available
Shanghai Chest Hospital
Shanghai, Shanghai 200030
ChinaSite Not Available
Sichuan Cancer Hospital
Chengdu, Sichuan 610000
ChinaSite Not Available
The First Affiliated Hospital Zhejiang University School of Medicine
Hangzhou, Zhejiang 310003
ChinaSite Not Available
The Second Affiliated Hospital of Zhejiang University College of Medicine
Hangzhou, Zhejiang 310009
ChinaSite Not Available
Zhejiang Cancer Hospital
Hangzhou, Zhejiang 310022
ChinaSite Not Available
Beijing Chest Hospital, Capital Medical University
Beijing, 101149
ChinaSite Not Available
University Cancer Hospital
Beijing, 100000
ChinaSite Not Available
Fudan University Shanghai Cancer Center
Shanghai, 200032
ChinaSite Not Available
CHU de Rennes - Hôpital Pontchaillou
Rennes, 35033
FranceSite Not Available
Institut Gustave Roussy
Villejuif Cedex, 94805
FranceSite Not Available
Healthcare Global Enterprises
Bengaluru, Karnataka 560027
IndiaSite Not Available
Bhaktivedanta Hospital & Research Institute
Thane, Maharashtra 401107
IndiaSite Not Available
Bhakti Vedanta Hospital & Research Institute
Thane/Mumbai, Maharashtra 401107
IndiaSite Not Available
Aichi Cancer Center Hospital
Nagoya, Aichi 464-8681
JapanSite Not Available
National Cancer Centre Singapore
Singapore, 168583
SingaporeSite Not Available
National University Hospital
Singapore, 119074
SingaporeSite Not Available
Hospital Vall D´Hebron
Barcelona, Cataluña 08035
SpainSite Not Available
Hospital Universitari Vall d'Hebron
Barcelona, 08035
SpainSite Not Available
National Taiwan University Hospital
Taipei, 10002
TaiwanSite Not Available
UC Irvine Health
Orange, California 92868-3201
United StatesSite Not Available
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.